Morningstar PitchBook Global BioPharma Unicorn

What this index holds, how it is built, and what its record does not cover. Morningstar Indexes, built with PitchBook.

What it tracks

The Morningstar PitchBook Global BioPharma Unicorn Index tracks the largest privately held, venture capital-backed companies in the BioPharma industry vertical with valuations of at least $1 billion. BioPharma companies exploit cellular and biomolecular processes to develop innovative therapeutics and technologies.

One industry vertical, biopharma, rather than the whole market.

Run by Morningstar Indexes, built with PitchBook. PrePost has no relationship with the provider and is not paid to list this index.

Read this first

Most of the record is backfilled

The index began on 2023-10-25. Its performance record starts 2021-03-22, so the years before 2023-10-25 are backfilled rather than live. A long-run return quoted for this index is mostly a backtest.

Private marks can be stale

The provider's own reporting notes that where transactions are infrequent, secondary-market marks can stay unchanged even as new information emerges.

How the index is built

FieldValue
ProviderMorningstar Indexes, built with PitchBook
InceptionOctober 25, 2023
Performance record startsMarch 22, 2021
Constituents24
WeightingMarket Capitalization
RebalanceQuarterly (next September 21, 2026)
CurrencyUSD
How constituents are pricedNot published as a rule. The provider's quarterly reporting on this family sources its secondary-market marks to Caplight, alongside Morningstar and PitchBook data.
Published methodologyNone that we could find. The index page, the family page and the provider's screener all link no rulebook or factsheet.
VariantsMorningstar PitchBook Global BioPharma Unicorn PR USD
Morningstar PitchBook Global BioPharma Unicorn GR USD
IdentifiersFS0000IE7R (Morningstar fund ID)

What is in it

Named constituents as of August 31, 2026.

PrePost has a sourced figure for 0 of the 24 named constituents.

Membership as the index provider published it on this date. PrePost shows which companies are in the index, not their weights.

CompanyPrePostEstimateConfidence
Biosplice TherapeuticsListedNo PrePost figure yet
Altos LabsListedNo PrePost figure yet
AbogenBioListedNo PrePost figure yet
Xaira TherapeuticsListedNo PrePost figure yet
insitroListedNo PrePost figure yet
ArsenalBioListedNo PrePost figure yet
PathosListedNo PrePost figure yet
SironaxListedNo PrePost figure yet
Isomorphic LabsListedNo PrePost figure yet
TrialsparkListedNo PrePost figure yet
NewLimitListedNo PrePost figure yet
ValoListedNo PrePost figure yet
RefleXionListedNo PrePost figure yet
Belief BioMedListedNo PrePost figure yet
Shanghai Cell Therapy GroupListedNo PrePost figure yet
Mammoth BiosciencesListedNo PrePost figure yet
Pharmaron NingboListedNo PrePost figure yet
Orca BioListedNo PrePost figure yet
Treeline BiosciencesListedNo PrePost figure yet
KallyopeListedNo PrePost figure yet
AdimabListedNo PrePost figure yet
Enveda BiosciencesListedNo PrePost figure yet
TrueBindingListedNo PrePost figure yet
Accutar BiotechListedNo PrePost figure yet

Verified means a full PrePost profile with sourced figures. Listed means the company is named here because a benchmark we track names it; PrePost has published no figure for it and does not rank it.

Vehicles that track it

None that PrePost tracks. That does not mean none exists: a product can track an index without PrePost having verified it, and PrePost lists a vehicle only once it can source what the vehicle is and what it holds.

Sources

An index is not an investment. Tracking one costs money and the product that tracks it may not hold what the index holds. This page describes the index, not any product, and is not investment advice.

Last updated 2026-09-12. See also how we verify and our disclaimer.